Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
TRVI Quote, Financials, Valuation and Earnings
Last price:
$12.83
Seasonality move
:
59.04%
Day range:
$12.60 - $13.16
52-week range:
$3.47 - $14.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.68x
Volume:
1.2M
Avg. volume:
2.2M
1-year change:
205.23%
Market cap:
$1.6B
Revenue:
--
EPS (TTM):
-$0.37
Earnings Data
Next earnings date for TRVI
Mar 17
2026
Most recent earnings per share
-$0.08
Beat by $0.02
(Nov 13/2025)
Consensus Estimate
-$0.10
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRVI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q4 | -- | -- | -- | -$0.10 | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.08 | -$0.10 | $0.02 |
| 08/07/2025 | Q2 | -- | -- | -$0.09 | -$0.10 | $0.01 |
| 05/08/2025 | Q1 | -- | -- | -$0.09 | -$0.12 | $0.03 |
| 03/18/2025 | Q4 | -- | -- | -$0.11 | -$0.12 | $0.01 |
| 11/06/2024 | Q3 | -- | -- | -$0.13 | -$0.11 | -$0.02 |
| 08/08/2024 | Q2 | -- | -- | -$0.12 | -$0.11 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.11 | -$0.09 | -$0.02 |
| 03/20/2024 | Q4 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.08 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.07 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.06 | -- | -- |
| 03/16/2023 | Q4 | -- | -- | -$0.06 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.12 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.14 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.24 | -- | -- |
| 03/17/2022 | Q4 | -- | -- | -$0.30 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.34 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.49 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.43 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$0.52 | -- | -- |
| 11/11/2020 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/12/2020 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.48 | -- | -- |
| 03/16/2020 | Q4 | -- | -- | -$0.37 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/12/2019 | Q2 | -- | -- | -$0.63 | -- | -- |
| 06/13/2019 | Q1 | -- | -- | -$0.35 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.41 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.34 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.22 | -- | -- |
Trevi Therapeutics, Inc. Earnings Questions
-
How Much did Trevi Therapeutics, Inc. Generate in Revenue Last Quarter?
Trevi Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Trevi Therapeutics, Inc. Beat Earnings Last Quarter?
Trevi Therapeutics, Inc. announced earnings per share of -$0.08 which represents a beat of analyst forecast a -$0.10 per share.
-
Is Trevi Therapeutics, Inc. Profitable?
Trevi Therapeutics, Inc. reported -$38K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Trevi Therapeutics, Inc. EPS Next Year?
Trevi Therapeutics, Inc.'s earnings are forecast to decrease from -$0.47 per share to -$0.37 per share next year representing a decrease of -21.24%.
-
When is Trevi Therapeutics, Inc.'s Earnings Date?
Trevi Therapeutics, Inc.'s next earnings date is March 17, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
